More ear­ly da­ta ma­nip­u­la­tion is­sues tied to No­var­tis block­buster as Na­ture re­tracts pa­per

No­var­tis’ block­buster gene ther­a­py Zol­gens­ma has proven to be a ma­jor suc­cess sto­ry as a spinal mus­cu­lar at­ro­phy treat­ment, help­ing chil­dren who might not oth­er­wise …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.